Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The United States specialty generics market reached a value of US$ 21 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Specialty generic drugs are the generic versions of specialty branded drugs once they lose patent protection. These drugs are used to treat life threatening and serious health conditions such as cancer, autoimmune diseases, epilepsy, HIV, hepatitis, multiple sclerosis, rheumatoid arthritis, etc.

Specialty generics are economical compared to specialty drugs as they don’t need to undergo the costly and time-consuming research and development procedures required for their branded versions. Moreover, marketing and promotional expenses for speciality generics are also lower compared to their branded versions. This results in significant savings for patients, government and healthcare providers. Moreover, the market is also being catalysed by a rising ageing population in the United States. This has resulted in an increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, hepatitis, HIV, autoimmune disease, etc. For instance, the American cancer society estimated a total of 1,762,450 new cancer cases and 606,880 deaths from cancer in the United States for 2019. Additionally, the patent expiration of several blockbuster branded specialty drugs is further expected to catalyse the market growth in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the United States specialty generics market, along with forecasts at the country level from 2021-2026. Our report has categorized the market based on route of administration, therapeutic application and distribution channel.

Breakup by Route of Administration:

  • Injectables
  • Oral
  • Others
     

Breakup by Therapeutic Application:

  • Oncology
  • Hepatitis
  • Multiple Sclerosis
  • HIV
  • Other Autoimmune Diseases
  • Others
     

Breakup by Distribution channel:

  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies
     

Competitive Landscape:

The leading players in the US specialty generics industry have also been examined in the report.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Route of Administration, Therapeutic Application, Distribution Channel
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License $ 1999
Five User License $ 2999
Corporate License $ 3999
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Global Specialty Generics Market: Introduction

    4.1    What are Specialty Generic Drugs?
    4.2    Types of Specialty Generics
5    Why are Specialty Generics So Lucrative?
6    Global Specialty Generics Market

    6.1    Market Overview
    6.2    Market Performance
    6.3    Market Breakup by Route of Administration
    6.4    Market Breakup by Therapeutic Application
    6.5    Market Breakup by Distribution Channel
    6.6    Market Breakup by Region
    6.7    Market Forecast
7    US Specialty Generics Market
    7.1    Market Overview
    7.2    Market Performance
    7.3    Impact of COVID-19
    7.4    Market Breakup by Route of Administration
    7.5    Market Breakup by Therapeutic Application
    7.6    Market Breakup by Distribution Channel
    7.7    Market Forecast
    7.8    SWOT Analysis
        7.8.1    Overview
        7.8.2    Strengths
        7.8.3    Weaknesses
        7.8.4    Opportunities
        7.8.5    Threats
    7.9    Value Chain Analysis
    7.10    Porters Five Forces Analysis
        7.10.1    Overview
        7.10.2    Bargaining Power of Buyers
        7.10.3    Bargaining Power of Suppliers
        7.10.4    Degree of Competition
        7.10.5    Threat of New Entrants
        7.10.6    Threat of Substitutes
    7.11    Key Market Drivers and Success Factors
8    Market Breakup by Route of Administration
    8.1    Injectables
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Oral
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Others
        8.3.1    Market Trends
        8.3.1    Market Forecast
9    Market Breakup by Therapeutic Application
    9.1    Oncology
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Hepatitis
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Multiple Sclerosis
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    HIV
        9.4.1    Market Trends
        9.4.2    Market Forecast
    9.5    Other Autoimmune Diseases
        9.5.1    Market Trends
        9.5.2    Market Forecast
    9.6    Others
        9.6.1    Market Trends
        9.6.2    Market Forecast
10    Market Breakup by Distribution Channel
    10.1    Retail Pharmacies
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    Specialty Pharmacies
        10.2.1    Market Trends
        10.2.2    Market Forecast
    10.3    Hospital Pharmacies
        10.3.1    Market Trends
        10.3.2    Market Forecast
11    Competitive Landscape
    11.1    Market Structure
    11.2    Key Players
    11.3    Profiles of Key Players

List of Figures

Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
Figure 3: Global: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2020
Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2020
Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 7: US: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
Figure 8: US: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
Figure 9: US: Specialty Generics Market: Breakup by Therapeutic Application (in %), 2020
Figure 10: US: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
Figure 11: US: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 12: US: Specialty Generics Industry: SWOT Analysis
Figure 13: US: Specialty Generics Industry: Value Chain Analysis
Figure 14: US: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 15: US: Specialty Generics Market (Administration through Injectables): Sales Value (in Million US$), 2015 & 2020
Figure 16: US: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: US: Specialty Generics Market (Oral Administration): Sales Value (in Million US$), 2015 & 2020
Figure 18: US: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: US: Specialty Generics Market (Other Routes of Administration): Sales Value (in Million US$), 2015 & 2020
Figure 20: US: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: US: Specialty Generics Market (Oncology): Sales Value (in Million US$), 2015 & 2020
Figure 22: US: Specialty Generics Market (Oncology) Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: US: Specialty Generics Market (Hepatitis): Sales Value (in Million US$), 2015 & 2020
Figure 24: US: Specialty Generics Market (Hepatitis) Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: US: Specialty Generics Market (Multiple Sclerosis): Sales Value (in Million US$), 2015 & 2020
Figure 26: US: Specialty Generics Market (Multiple Sclerosis) Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: US: Specialty Generics Market (HIV): Sales Value (in Million US$), 2015 & 2020
Figure 28: US: Specialty Generics Market (HIV) Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: US: Specialty Generics Market (Other Autoimmune Diseases): Sales Value (in Million US$), 2015 & 2020
Figure 30: US: Specialty Generics Market (Other Autoimmune Diseases) Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: US: Specialty Generics Market (Other Applications): Sales Value (in Million US$), 2015 & 2020
Figure 32: US: Specialty Generics Market (Other Applications) Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: US: Specialty Generics Market: Sales Through Retail Pharmacies (in Million US$), 2015 & 2020
Figure 34: US: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Million US$), 2021-2026
Figure 35: US: Specialty Generics Market: Sales Through Specialty Pharmacies (in Million US$), 2015 & 2020
Figure 36: US: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Million US$), 2021-2026
Figure 37: US: Specialty Generics Market: Sales Through Hospital Pharmacies (in Million US$), 2015 & 2020
Figure 38: US: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Million US$), 2021-2026

List of Tables

Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 2: US: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 3: US: Specialty Generics Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 4: US: Specialty Generics Market Forecast: Breakup by Therapeutic Application (in Million US$), 2021-2026
Table 5: US: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: US: Specialty Generics Market: Competitive Structure
Table 7: US: Specialty Generics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Question Answered in this Report

The United States specialty generics market was valued at US$ 21 Billion in 2020.

We expect the United States specialty generics market to exhibit a CAGR of around 10% during 2021-2026.

The increasing prevalence of various life-threatening diseases, such as cancer, multiple sclerosis, hepatitis, HIV, etc., is one of the factors driving the United States specialty generics market. 

With the outbreak of the COVID-19 in the United States, there is a significant rise in the R&D activities pertaining to specialty generic drugs for combating the spread of coronavirus infection.

Based on the route of administration, the United States specialty generics market can be segmented into injectables, oral, and others. Currently, injectables hold the majority of the total market share.

Based on the therapeutic application, the United States specialty generics market has been segregated into oncology, multiple sclerosis, hepatitis, HIV, other autoimmune diseases, and others, where oncology currently represents the largest segment.

Based on the distribution channel, the United States specialty generics market can be categorized into retail pharmacies, specialty pharmacies, and hospital pharmacies. Currently, retail pharmacies exhibit a clear dominance in the market.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 1999

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links